Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2233–2256 of 2,513 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Ischemic Stroke
Interventions: Tigertriever revascularization device; Device
Lead sponsor: Rapid Medical; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 16
States / cities: Los Angeles, California • Thousand Oaks, California • Coral Springs, Florida + 12 more

Conditions: Refractory Infantile Spasms
Interventions: JBPOS0101; Drug
Lead sponsor: Bio-Pharm Solutions Co., Ltd.; Industry
Eligibility: 6 Months to 36 Months
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 17
States / cities: Little Rock, Arkansas • Los Angeles, California • San Francisco, California + 13 more

Conditions: Healthy Participants
Interventions: Perampanel; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 20 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Anaheim, California

Conditions: Rapid HIV Screening
Interventions: A: Nontargeted rapid HIV screening, B: Enhanced targeted rapid HIV screening, C: Traditional targeted rapid HIV screening; Other
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 16 Years and older
Enrollment: 76,235 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 4
States / cities: Oakland, California • Denver, Colorado • Baltimore, Maryland + 1 more

Conditions: Type 2 Diabetes
Interventions: Bromocriptine mesylate; Drug
Lead sponsor: VeroScience; Industry
Eligibility: 10 Years to 17 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 5
States / cities: Phoenix, Arizona • New Haven, Connecticut • Miami, Florida + 2 more

Conditions: Post-Traumatic Stress Disorder
Interventions: Sleep data recording, PET scan - waking, PET scan - REM Sleep; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Ewing Sarcoma
Interventions: LX-101; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 10 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2033
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Parkinson Disease
Interventions: K0706, Placebo; Drug
Lead sponsor: Sun Pharma Advanced Research Company Limited; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 5
States / cities: Long Beach, California • Panorama City, California • DeLand, Florida + 2 more

Conditions: Healthy Adult Subjects
Interventions: Losmapimod 15 mg oral tablet, Losmapimod two 7.5 mg oral tablets, Losmapimod one 15 mg oral tablet; Drug
Lead sponsor: Fulcrum Therapeutics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Ventricular Tachycardia (VT)
Interventions: Implantable Cardioverter Defibrillator (ICD), Catheter Ablation; Device · Procedure
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: HIV, Substance Abuse, HIV Infections
Interventions: Intensive Case Management; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 2
States / cities: New Haven, Connecticut • Waterbury, Connecticut

Conditions: COVID-19
Interventions: Standard implementation webinar and online training, Virtual facilitation; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Sleep Apnea, Sleep Disordered Breathing
Interventions: CPAP machine with MNT algorithm; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Major Depressive Disorder
Interventions: Ketamine infusion, Midazolam infusion; Drug
Lead sponsor: Yale University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Major Depressive Disorder, Anxiety Disorder
Interventions: Ketamine, Midazolam; Drug
Lead sponsor: Yale University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: New Haven, Connecticut

Conditions: Cerebrovascular Accident
Interventions: Fast Walking with Fast Functional Electrical Stimulation (FES) Training, Fast Walking; Device · Other
Lead sponsor: Emory University; Other
Eligibility: 30 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Brain Metastases, Brain Cancer
Interventions: 18F-Fluciclovine; Drug
Lead sponsor: Baptist Health South Florida; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Oral Intake Reduced
Interventions: Slow eating condition, Fast eating condition; Behavioral
Lead sponsor: Texas Christian University; Other
Eligibility: 19 Years to 65 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Type 1 Diabetes Mellitus
Interventions: Ultra-Rapid Lispro, Insulin Lispro; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 471 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 32
States / cities: Concord, California • Fresno, California • Greenbrae, California + 28 more

Conditions: Paroxysmal Supraventricular Tachycardia
Interventions: Etripamil, Placebo, Etripamil Test Dose; Drug
Lead sponsor: Milestone Pharmaceuticals Inc.; Other
Eligibility: 18 Years and older
Enrollment: 1,097 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 54
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Cerritos, California + 44 more

Conditions: HIV Pre-exposure Prophylaxis, PrEP
Interventions: PrEP Uptake with Rapid Start, Pre-Exposure Prophylaxis (PrEP) Persistence; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Cancer
Interventions: REST; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Post Operative Pain Control
Interventions: Exparel 266 MG Per 20 ML Injection, Placebo; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Amblyopia
Interventions: levodopa/carbidopa, patching; Drug · Device
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 8 Years to 17 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Treatment With Intent to Generate Endovascular Reperfusion

A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients

Study to Evaluate Bioavailability of a Single 12 mg Dose of Perampanel for Three Intravenous Infusion Durations Relative to a Single 12 mg Perampanel Oral Tablet in Healthy Subjects

The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects

Neurobiological Correlates of Post Traumatic Stress Disorder (PTSD) During Rapid Eye Movement (REM) Sleep

RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCT

Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease

Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets

Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial

Transitions: Linkages From Jail To Community

COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists

Multinight CPAP for Sleep Apnea Patients

Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy

Ketamine Infusion for Adolescent Depression and Anxiety

Stroke Gait Rehabilitation Using Functional Electrical Stimulation

Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis

The Effect of Changing the Eating Speed on Energy Intake

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy

Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT).

HIV Pre-Exposure Prophylaxis (PrEP) Linkage With Immediate Medications in the Emergency Department Study

Rapid Easy Strength Training (REST) to Improve Function in Late Stage Cancer

Pectoralis and Serratus Muscle Blocks

Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia